Literature DB >> 24707051

Exploiting polypharmacology for drug target deconvolution.

Taranjit Singh Gujral1, Leonid Peshkin, Marc W Kirschner.   

Abstract

Polypharmacology (action of drugs against multiple targets) represents a tempting avenue for new drug development; unfortunately, methods capable of exploiting the known polypharmacology of drugs for target deconvolution are lacking. Here, we present an ensemble approach using elastic net regularization combined with mRNA expression profiling and previously characterized data on a large set of kinase inhibitors to identify kinases that are important for epithelial and mesenchymal cell migration. By profiling a selected optimal set of 32 kinase inhibitors in a panel against six cell lines, we identified cell type-specific kinases that regulate cell migration. Our discovery of several informative kinases with a previously uncharacterized role in cell migration (such as Mst and Taok family of MAPK kinases in mesenchymal cells) may represent novel targets that warrant further investigation. Target deconvolution using our ensemble approach has the potential to aid in the rational design of more potent but less toxic drug combinations.

Keywords:  cancer cell migration; perturbation biology; predictive modeling; regularized regression; systems pharmacology

Mesh:

Substances:

Year:  2014        PMID: 24707051      PMCID: PMC3977247          DOI: 10.1073/pnas.1403080111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Global mapping of pharmacological space.

Authors:  Gaia V Paolini; Richard H B Shapland; Willem P van Hoorn; Jonathan S Mason; Andrew L Hopkins
Journal:  Nat Biotechnol       Date:  2006-07       Impact factor: 54.908

Review 2.  Polypharmacology - foe or friend?

Authors:  Jens-Uwe Peters
Journal:  J Med Chem       Date:  2013-08-22       Impact factor: 7.446

3.  A simplified method for quantifying cell migration/wound healing in 96-well plates.

Authors:  Patrick Y K Yue; Emily P Y Leung; N K Mak; Ricky N S Wong
Journal:  J Biomol Screen       Date:  2010-03-05

4.  EphA3 maintains tumorigenicity and is a therapeutic target in glioblastoma multiforme.

Authors:  Bryan W Day; Brett W Stringer; Fares Al-Ejeh; Michael J Ting; John Wilson; Kathleen S Ensbey; Paul R Jamieson; Zara C Bruce; Yi Chieh Lim; Carolin Offenhäuser; Sara Charmsaz; Leanne T Cooper; Jennifer K Ellacott; Angus Harding; Lucie Leveque; Po Inglis; Suzanne Allan; David G Walker; Martin Lackmann; Geoffrey Osborne; Kum Kum Khanna; Brent A Reynolds; Jason D Lickliter; Andrew W Boyd
Journal:  Cancer Cell       Date:  2013-02-11       Impact factor: 31.743

5.  TBK1 directly engages Akt/PKB survival signaling to support oncogenic transformation.

Authors:  Yi-Hung Ou; Michael Torres; Rosalyn Ram; Etienne Formstecher; Christina Roland; Tzuling Cheng; Rolf Brekken; Ryan Wurz; Andrew Tasker; Tony Polverino; Seng-Lai Tan; Michael A White
Journal:  Mol Cell       Date:  2011-02-18       Impact factor: 17.970

6.  Regularization Paths for Generalized Linear Models via Coordinate Descent.

Authors:  Jerome Friedman; Trevor Hastie; Rob Tibshirani
Journal:  J Stat Softw       Date:  2010       Impact factor: 6.440

Review 7.  Target deconvolution techniques in modern phenotypic profiling.

Authors:  Jiyoun Lee; Matthew Bogyo
Journal:  Curr Opin Chem Biol       Date:  2013-01-18       Impact factor: 8.822

8.  ErbB4 increases the proliferation potential of human lung cancer cells and its blockage can be used as a target for anti-cancer therapy.

Authors:  Alex Starr; Joel Greif; Akiva Vexler; Maia Ashkenazy-Voghera; Valery Gladesh; Chanan Rubin; Gabriele Kerber; Sylvia Marmor; Shahar Lev-Ari; Moshe Inbar; Yosef Yarden; Rami Ben-Yosef
Journal:  Int J Cancer       Date:  2006-07-15       Impact factor: 7.396

9.  Heterotrimerization of the growth factor receptors erbB2, erbB3, and insulin-like growth factor-i receptor in breast cancer cells resistant to herceptin.

Authors:  Xiaoping Huang; Lizhi Gao; Shuiliang Wang; James L McManaman; Ann D Thor; Xiaohe Yang; Francisco J Esteva; Bolin Liu
Journal:  Cancer Res       Date:  2010-01-26       Impact factor: 12.701

10.  Analysis of the myosin-II-responsive focal adhesion proteome reveals a role for β-Pix in negative regulation of focal adhesion maturation.

Authors:  Jean-Cheng Kuo; Xuemei Han; Cheng-Te Hsiao; John R Yates; Clare M Waterman
Journal:  Nat Cell Biol       Date:  2011-03-20       Impact factor: 28.824

View more
  34 in total

Review 1.  Systems Pharmacology Links GPCRs with Retinal Degenerative Disorders.

Authors:  Yu Chen; Krzysztof Palczewski
Journal:  Annu Rev Pharmacol Toxicol       Date:  2015-03-23       Impact factor: 13.820

2.  Discovery of Covalent CDK14 Inhibitors with Pan-TAIRE Family Specificity.

Authors:  Fleur M Ferguson; Zainab M Doctor; Scott B Ficarro; Christopher M Browne; Jarrod A Marto; Jared L Johnson; Tomer M Yaron; Lewis C Cantley; Nam Doo Kim; Taebo Sim; Matthew J Berberich; Marian Kalocsay; Peter K Sorger; Nathanael S Gray
Journal:  Cell Chem Biol       Date:  2019-03-28       Impact factor: 8.116

3.  A systems approach to traditional oriental medicine.

Authors:  Hyun Uk Kim; Jae Yong Ryu; Jong Ok Lee; Sang Yup Lee
Journal:  Nat Biotechnol       Date:  2015-03       Impact factor: 54.908

Review 4.  Drug combination therapy increases successful drug repositioning.

Authors:  Wei Sun; Philip E Sanderson; Wei Zheng
Journal:  Drug Discov Today       Date:  2016-05-27       Impact factor: 7.851

5.  Gini Coefficients as a Single Value Metric to Define Chemical Probe Selectivity.

Authors:  Andrei Ursu; Jessica L Childs-Disney; Alicia J Angelbello; Matthew G Costales; Samantha M Meyer; Matthew D Disney
Journal:  ACS Chem Biol       Date:  2020-07-09       Impact factor: 5.100

6.  Fragment-Based Discovery of a Dual pan-RET/VEGFR2 Kinase Inhibitor Optimized for Single-Agent Polypharmacology.

Authors:  Brendan Frett; Francesca Carlomagno; Maria Luisa Moccia; Annalisa Brescia; Giorgia Federico; Valentina De Falco; Brittany Admire; Zhongzhu Chen; Wenqing Qi; Massimo Santoro; Hong-yu Li
Journal:  Angew Chem Int Ed Engl       Date:  2015-06-30       Impact factor: 15.336

7.  Target Deconvolution of a Multikinase Inhibitor with Antimetastatic Properties Identifies TAOK3 as a Key Contributor to a Cancer Stem Cell-Like Phenotype.

Authors:  Yansong Bian; Yaroslav Teper; Lesley A Mathews Griner; Taylor J Aiken; Vivek Shukla; Rajarshi Guha; Paul Shinn; Hong-Wu Xin; Holger Pflicke; Astin S Powers; Dandan Li; Jian-Kang Jiang; Paresma Patel; Steven A Rogers; Jeffrey Aubé; Marc Ferrer; Craig J Thomas; Udo Rudloff
Journal:  Mol Cancer Ther       Date:  2019-08-08       Impact factor: 6.261

Review 8.  Opportunities for Host-targeted Therapies for Malaria.

Authors:  Elizabeth K K Glennon; Selasi Dankwa; Joseph D Smith; Alexis Kaushansky
Journal:  Trends Parasitol       Date:  2018-08-16

9.  Polypharmacology of N6-(3-Iodobenzyl)adenosine-5'-N-methyluronamide (IB-MECA) and Related A3 Adenosine Receptor Ligands: Peroxisome Proliferator Activated Receptor (PPAR) γ Partial Agonist and PPARδ Antagonist Activity Suggests Their Antidiabetic Potential.

Authors:  Jinha Yu; Seyeon Ahn; Hee Jin Kim; Moonyoung Lee; Sungjin Ahn; Jungmin Kim; Sun Hee Jin; Eunyoung Lee; Gyudong Kim; Jae Hoon Cheong; Kenneth A Jacobson; Lak Shin Jeong; Minsoo Noh
Journal:  J Med Chem       Date:  2017-08-28       Impact factor: 7.446

10.  Kinesin superfamily protein Kif26b links Wnt5a-Ror signaling to the control of cell and tissue behaviors in vertebrates.

Authors:  Michael W Susman; Edith P Karuna; Ryan C Kunz; Taranjit S Gujral; Andrea V Cantú; Shannon S Choi; Brigette Y Jong; Kyoko Okada; Michael K Scales; Jennie Hum; Linda S Hu; Marc W Kirschner; Ryuichi Nishinakamura; Soichiro Yamada; Diana J Laird; Li-En Jao; Steven P Gygi; Michael E Greenberg; Hsin-Yi Henry Ho
Journal:  Elife       Date:  2017-09-08       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.